Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 23, 2015
SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015R García-Campelo, R Bernabé, M Cobo, et al.
American Journal of Clinical Oncology|February 1, 1992
A prospective randomized trial of continuous infusion 5-fluorouracil (5-FU) versus 5-FU plus cisplatin in patients with advanced colorectal cancer. A trial of the Spanish Cooperative Group for Digestive Tract Tumor Therapy (T.T.D.)E Díaz-Rubio, J Jimeno, A Antón, et al.
Lung Cancer (Amsterdam, Netherlands)|March 16, 2000
Economic evaluation in a randomized phase III clinical trial comparing gemcitabine/cisplatin and etoposide/cisplatin in non-small cell lung cancerJ A Sacristán, T Kennedy-Martin, R Rosell, et al.
Seminars in Oncology|November 5, 1997
Dose-escalated paclitaxel in 1-hour infusion with a fixed dose of cisplatin in previously untreated advanced ovarian cancer: a phase II trial of the Spanish Group for Ovarian CancerA Cervantes, C Mendiola, J M del Campo, et al.
Anti-Cancer Drugs|July 11, 1998
Granisetron plus methylprednisolone for the control of high-dose cisplatin-induced emesisJ P Kleisbauer, C García-Girón, M Antimi, et al.
Seminars in Oncology|August 1, 1997
A sequence-dependent paclitaxel/etoposide phase II trial in patients with non-small cell lung cancerR Rosell, E Felip, B Massuti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1992
Etoposide (E) + epirubicin (E) + cisplatin (P) combination chemotherapy (EEP) in advanced gastric cancer: negative impact on clinical outcome. Spanish Cooperative Group for GI Tumor Therapy (T.T.D.)E Díaz-Rubio, J Jimeno, E Aranda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Superiority of sequential versus concurrent administration of paclitaxel with etoposide in advanced non-small cell lung cancer: comparison of two Phase II trialsE Felip, B Massuti, C Camps, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 3, 2005
Phase II trial of the novel taxane BMS-184476 as second-line in non-small-cell lung cancerC Camps, E Felip, J M Sanchez, et al.
American Journal of Clinical Oncology|April 16, 1998
Seventy-two hour epirubicin infusion plus quinidine in unresectable and metastatic adenocarcinoma of the pancreas: a phase II trialA Abad, B Massuti, E Blanco, et al.
Pageof 4